Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

BACKGROUND: Tamoxifen and raloxifene reduce the risk of breast cancer in women at elevated risk of disease, but the duration of the effect is unknown. We assessed the effectiveness of selective oestrogen receptor modulators (SERMs) on breast cancer incidence. METHODS: We did a meta-analysis with ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuzick, Jack, Sestak, Ivana, Bonanni, Bernardo, Costantino, Joseph P, Cummings, Steve, DeCensi, Andrea, Dowsett, Mitch, Forbes, John F, Ford, Leslie, LaCroix, Andrea Z, Mershon, John, Mitlak, Bruce H, Powles, Trevor, Veronesi, Umberto, Vogel, Victor, Wickerham, D Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671272/
https://www.ncbi.nlm.nih.gov/pubmed/23639488
http://dx.doi.org/10.1016/S0140-6736(13)60140-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671272/
https://www.ncbi.nlm.nih.gov/pubmed/23639488
http://dx.doi.org/10.1016/S0140-6736(13)60140-3

Ejemplares similares